Document and Entity Information Document Type Document Annual Report Document Period End Date Document Transition Report Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company ICFR Auditor Attestation Flag Document Financial Statement Error Correction [Flag] Entity Shell Company Entity Public Float Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag Auditor Name Auditor Firm ID Auditor Location CONSOLIDATED BALANCE SHEETS Statement [Table] Statement [Table] Statement [Line Items] Statement Assets [Abstract] ASSETS Assets, Current [Abstract] Current Assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Short-term Investments Short-term deposit (Note 8) Nontrade Receivables, Current Other accounts receivable Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets (Note 4) Assets, Current Total current assets Assets, Noncurrent [Abstract] Long-Term Assets: Prepaid Expense and Other Assets, Noncurrent Prepaid expenses and other long-term assets Restricted Cash, Noncurrent Restricted Cash Operating Lease, Right-of-Use Asset Operating lease right of use asset (Note 5) Operating lease right of use asset Property, Plant and Equipment, Net Depreciated cost Property and Equipment, Net (Note 6) Other Assets, Noncurrent Total Long-Term Assets Assets Total assets Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) Liabilities, Current [Abstract] Current Liabilities: Accounts Payable, Current Accounts payables Accrued Liabilities, Current Accrued expenses Operating Lease, Liability, Current Operating lease liability (Note 5) Employee-related Liabilities, Current Employees related liability Liabilities, Current Total current liabilities Liabilities, Noncurrent [Abstract] Long-Term Liabilities: Operating Lease, Liability, Noncurrent Operating lease liability (Note 5) Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent Warrants liability (Note 9) Liabilities, Noncurrent Total long-term liabilities Liabilities Total liabilities Stockholders' Equity Attributable to Parent [Abstract] Stockholders' Deficit: Common Stock, Value, Issued Stock capital: (Note 10) Additional Paid in Capital, Common Stock Additional paid-in-capital Treasury Stock, Common, Value Treasury stocks Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated deficit Stockholders' Equity Attributable to Parent Balance Balance Total stockholders' deficit Liabilities and Equity Total liabilities and stockholders' deficit Common Stock, Par or Stated Value Per Share Common Stock, par value (in dollars per share) Common Stock, Shares Authorized Common Stock, shares authorized Common Stock, Shares, Issued Common Stock, shares issued Common Stock, Shares, Outstanding Common Stock, shares outstanding CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Operating Expenses [Abstract] Operating expenses: Research and Development Expense Research and development expense Research and development, net (Note 12) General and Administrative Expense General and administrative Operating Income (Loss) Operating loss Represents the amount of financial expenses (income), net during the period. Financial Expenses Income Net Financial income (expense), net Amount of expense (income) related to adjustment to fair value of warrant liability and stock issuance costs. Fair Value Adjustments Of Warrants And Stock Issuance Costs Gain on change in fair value of Warrants liability (Note 9) Net loss Net loss Earnings Per Share, Basic Basic net loss per share Earnings Per Share, Diluted Diluted net loss per share Weighted Average Number of Shares Outstanding, Basic Weighted average number of shares outstanding used in computing basic net loss per share Weighted Average Number of Shares Outstanding, Diluted Weighted average number of shares outstanding used in computing diluted net loss per share CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) Equity Components [Axis] Equity Component [Domain] Common Stock [Member] Common Stock Common stock Additional Paid-in Capital [Member] Additional paid-in capital Treasury Stocks [Member] Treasury stocks Accumulated Deficit [Member] Accumulated deficit Shares, Outstanding Balance (in shares) Balance (in shares) Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Stock-based compensation related to stock and options granted to directors and employees Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Stock-based compensation related to stock and options granted to directors and employees (in shares) Represents the information pertaining to issuance under at the market. Issuance Of Shares At The Market Issuance of shares in at-the-market (ATM) offering (Note 10) Represents the information pertaining to issuance under at the market. Issuance Of Share Value Issuance of shares in at-the-market (ATM) offering (Note 10) (in shares) Number of shares value for private placement. Issuance of shares for private placement value Issuance of shares for private placement (Note 7) Number of shares issued for private placement. Issuance of shares for private placement Issuance of shares for private placement (Note 7) (shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Amount of options, Exercised Exercise of options (in shares) CONSOLIDATED STATEMENTS OF CASH FLOWS Net Cash Provided by (Used in) Operating Activities [Abstract] Cash flows from operating activities: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Depreciation Depreciation Stock or Unit Option Plan Expense Stock-based compensation related to options granted to employees and directors Increase (Decrease) in Operating Lease Liability Change in operating lease liability, net Decrease in lease liabiliity It represents the increase (decrease) during the reporting period in accounts receivable and prepaid expenses. Increase Decrease In Accounts Receivable and Prepaid Expenses Decrease (increase) in prepaid expenses and other accounts receivable Increase (Decrease) in Accounts Payable, Trade Increase (decrease) in trade payables Fair Value Adjustment of Warrants Change in fair value of Warrants liability Gain on change in fair value of warrants (Note 9) Increase (Decrease) in Accrued Liabilities Increase (decrease) in employees related liability and accrued expenses Net Cash Provided by (Used in) Operating Activities Total net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash flows from investing activities: Payments to Acquire Property, Plant, and Equipment Purchase of property and equipment Payments for (Proceeds from) Investments Changes in short-term deposit Net Cash Provided by (Used in) Investing Activities Total net cash provided by investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash flows from financing activities: Amount of cash inflow from at the market. Proceeds From At The Market Proceeds from issuance of shares in at-the-market (ATM) offering (Note 10) Proceeds from Issuance of Private Placement Proceeds from Issuance of shares for private placement (Note 10) Net Cash Provided by (Used in) Financing Activities Total net cash provided by financing activities Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash, cash equivalents and restricted cash at end of the period Cash, cash equivalents and restricted cash at the beginning of the period Non-Cash Activities: Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Right of use ("ROU") asset recognized with corresponding lease liability, resulted from new lease agreement (Note 5) The amount of decrease in right of use asset from lease modification. Right Of Use Asset Decreased, Resulted From Lease Modification ROU asset decreased, resulted from lease modification (Note 5) The amount of decrease in lease liability from lease modification. Lease Liability Decreased, Resulted From Lease Modification Lease liability decreased, resulted from lease modification (Note 5) The amount of lease expense from lease modification. Lease Expense, Resulted From Lease Modification Finance expenses resulted from lease modification (Note 5) GENERAL Business Description and Basis of Presentation [Text Block] GENERAL SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Significant Accounting Policies [Text Block] SIGNIFICANT ACCOUNTING POLICIES RESEARCH AND LICENSE AGREEMENT The entire disclosure on research and license agreement entered by the entity. Research and License Agreement [Text Block] RESEARCH AND LICENSE AGREEMENT PREPAID EXPENSES The entire disclosure for Prepaid Expenses. Prepaid Expenses Disclosures [Text Block] PREPAID EXPENSES LEASES Lessee, Operating Leases [Text Block] LEASES PROPERTY AND EQUIPMENT Property, Plant and Equipment Disclosure [Text Block] PROPERTY AND EQUIPMENT COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] COMMITMENTS AND CONTINGENCIES SHORT TERM DEPOSITS The entire disclosure of the components short-term deposits. Short Term Deposits Disclosure [Text Block] SHORT TERM DEPOSITS WARRANTS LIABILITY The entire disclosure of warrants liability. Warrants Liability Disclosure [Text Block] WARRANTS LIABILITY STOCK CAPITAL Stockholders' Equity Note Disclosure [Text Block] STOCK CAPITAL FAIR VALUE MEASUREMENT Fair Value Disclosures [Text Block] FAIR VALUE MEASUREMENT RESEARCH AND DEVELOPMENT, NET Research, Development, and Computer Software Disclosure [Text Block] RESEARCH AND DEVELOPMENT, NET TAXES ON INCOME Income Tax Disclosure [Text Block] TAXES ON INCOME TRANSACTIONS WITH RELATED PARTIES Related Party Transactions Disclosure [Text Block] TRANSACTIONS WITH RELATED PARTIES SUBSEQUENT EVENTS Subsequent Events [Text Block] SUBSEQUENT EVENTS Basis of Accounting, Policy [Policy Text Block] Basis of presentation Use of Estimates, Policy [Policy Text Block] Use of estimates Foreign Currency Transactions and Translations Policy [Policy Text Block] Financial statements in U.S. dollars Consolidation, Policy [Policy Text Block] Principles of consolidation Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Cash and cash equivalents and restricted cash Disclosure of accounting policy for short-term deposits. Short Term Deposits Policy [Policy Text Block] Short-term deposits Property, Plant and Equipment, Policy [Policy Text Block] Property and equipment Disclosure of accounting policy for severance Pay. Severance Pay Policy [Policy Text Block] Accrued post-employment benefit Fair Value of Financial Instruments, Policy [Policy Text Block] Fair value of financial instruments Share-Based Payment Arrangement [Policy Text Block] Accounting for stock-based compensation Earnings Per Share, Policy [Policy Text Block] Basic and diluted net loss per share Research and Development Expense, Policy [Policy Text Block] Research and development expenses, net Income Tax, Policy [Policy Text Block] Income taxes Lessee, Leases [Policy Text Block] Lease accounting Disclosure of accounting policy for treasury stock. Treasury Stock Policy [Policy Text Block] Treasury Stock Commitments and Contingencies, Policy [Policy Text Block] Commitments and Contingencies New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Standards Updates Not Yet Effective Tabular disclosure of depreciation rates for property, plant and equipment over the estimated useful lives. Schedule Of Depreciation Rates For Property Plant And Equipment [Table Text Block] Schedule of annual depreciation rates Lease, Cost [Table Text Block] Schedule of supplemental cash flow information related to operating leases Lessee, Operating Lease, Liability, Maturity [Table Text Block] Schedule of future lease payments under operating leases Property, Plant and Equipment [Table Text Block] Schedule of Property, plant and equipment Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of fair value assumptions used for the stock options granted Share-based Compensation, Stock Options, Activity [Table Text Block] Summary of the Company's option activity Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block] Schedule of options outstanding have been separated into exercise prices Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block] Schedule of compensation expense for restricted stock is based on fair market value at the grant date Tabular disclosure includes the number and weighted-average issue prices for warrants issued to services providers that were outstanding at the beginning and end of the year, and issued during the year. Schedule Stock Awards Activity Related To Service Providers [Table Text Block] Schedule of total stock-based compensation expense Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Schedule of assumptions used to determine fair value of July 2023 warrants Tabular disclosure of research and development. Research and Development Disclosure [Table Text Block] Schedule of Research and development, Net Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule significant components of the Company's deferred tax assets Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Schedule of loss from continuing operations, before taxes on income The percentage of targeted reduction in headcount. Percentage of Targeted Reduction in Headcount Percentage of targeted reduction in headcount The percentage of reduction in key operating expenses under the strategic realignment. Restructuring, Percentage Of Reduction In Operating Expenses Percentage of reduction In operating expenses Severance Costs Accrued expenses Property, Plant and Equipment [Table] Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Domain] Office Equipment [Member] Office furniture and equipment Computer Equipment [Member] Computer software and electronic equipment Represents information pertaining to laboratory equipment. Laboratory Equipment [Member] Laboratory equipment Property, Plant and Equipment [Line Items] Property, Plant and Equipment The depreciation rate recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Property Plant and Equipment Depreciation Rates Property Plant and Equipment Depreciation Rates Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay Amount of severance pay equal to monthly deposits Represents the percentage of all net sales royalty that the company will pay if the making, producing, manufacturing, using, marketing, selling, importing or exporting of such licensed product is covered by a valid claim or is covered by orphan drug status. Percentage of Royalty Payment if Licensed Product Covered by Valid Claim or Orphan Drug Status Percentage of royalty payment if licensed product covered by valid claim or orphan drug status Represents the percentage of all net sales royalty that the company will pay if the making, producing, manufacturing, using, marketing, selling, importing or exporting of such licensed product is not covered by a valid claim or is not covered by orphan drug status. Percentage of Royalty Payment If Licensed Product Not Covered by Valid Claim or Orphan Drug Status Percentage of royalty payment if licensed product not covered by valid claim or orphan drug status This element represents the validity of the royalties' payments by the company not covered by a Valid Claim or Orphan Drug Status in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Validity of Royalty Payment Not Covered by Valid Claim or Orphan Drug Status Validity of royalty payment not covered by valid claim or orphan drug status Disclosure of prepaid expenses PREPAID EXPENSES [Table] Insurance Type and Tier Identifier [Axis] Type and Tier Identifier [Domain] Directors and Officers Liability Insurance [Member] Directors insurance Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. PREPAID EXPENSES [Line Item] PREPAID EXPENSES Prepaid Expense Prepaid expense Lessee, Lease, Description [Table] Consolidated Entities [Axis] Consolidated Entities [Domain] Subsidiaries [Member] Representing information pertaining to Brainstorm Cell Therapeutics, Ltd. a wholly-owned subsidiary formed in Israel, which conducts all of the research and development activities of the company. BCT [Member] BCT Lessee, Lease, Description [Line Items] LEASES Area of Land Area of land Lessee, Operating Lease, Term of Contract Term of lease Lessee, Operating Lease, Renewal Term Extension term of lease Sale Leaseback Transaction, Monthly Rental Payments Monthly lease payments The increase (decrease) during the period in the operating lease right of use asset. Increase (Decrease) in Operating Lease Right Of Use Asset Right of use Operating Lease, Liability Operating lease liability Total lease liability balance Lease, Cost Lease costs Operating Lease, Weighted Average Remaining Lease Term Operating lease, weighted average remaining lease term Operating Lease, Weighted Average Discount Rate, Percent Operating lease, weighted average discount rate percent Operating Lease, Payments Cash payments for operating leases The amount of operating lease expense (income). Operating Lease Expense (Income) Operating lease expense The amount of finance lease expense (income). Finance Lease Expenses (Income) Finance lease expense (income) Lessee, Operating Lease, Liability, to be Paid, Year One 2024 Lessee, Operating Lease, Liability, to be Paid, Year Two 2025 Lessee, Operating Lease, Liability, to be Paid, Year Three 2026 Lessee, Operating Lease, Liability, to be Paid Total future lease payments Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less imputed interest Leasehold improvements Property, Plant and Equipment, Net [Abstract] Composition: Property, Plant and Equipment, Gross Cost Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Accumulated depreciation Loss Contingencies [Table] Statistical Measurement [Axis] Statistical Measurement [Domain] Minimum [Member] Minimum Maximum [Member] Maximum Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] Legal Entity [Axis] Entity [Domain] Represents information pertaining to israel innovation authorities. Israel Innovation Authorities [Member] Israel Innovation Authorities Loss Contingencies [Line Items] COMMITMENTS AND CONTINGENCIES The percentage of royalty payments obligated to be paid as per the agreement for grants received for participation in research Percentage Of Royalty Payments Agreed For Grants Percentage of royalty payments agreed for grants The underlying basis on which the grants are linked. Grants Underlying Basis Grants underlying basis The cash inflow from grants received during the period. Amounts Of Grants Received Amounts of grants received The number of shareholders who filed complaints. Number Of Shareholders, Filed Complaints Number Of Shareholders Tabular disclosure of short term deposits. Schedule of Short Term Deposits [Table] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Short Term Deposits [Line Items] SHORT TERM DEPOSITS Investment Interest Rate Annual interest rate on bank deposits Deposits Assets, Current Short term deposits Class of Warrant or Right [Table] Warrant [Member] Private placement warrants Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Represents the information pertaining to July 2023 warrants. July 2023 Warrants [Member] July 2023 warrants Class of Warrant or Right [Line Items] WARRANTS LIABILITY Stock Issued During Period, Shares, New Issues Aggregate shares sold Class of Warrant or Right, Number of Securities Called by Warrants or Rights Class of Warrant or Right, Number of Securities Called by Warrants or Rights Warrants to purchase shares of common stock The cash inflow associated with the amount received from issuance of common stock and from holders exercising their stock warrants. Proceeds from Issuance of Common Stock and Warrants Exercises Gross proceeds The carrying amount of issuance costs related to warrants liability and equity. Warrants Liability and Equity, Issuance Costs Total issuance costs The carrying amount of issuance costs related to warrants liability. Warrant Liability, Issuance Costs Total issuance costs allocated to warrants liability The carrying amount of issuance costs related to equity. Equity, Issuance Costs Total issuance costs allocated to equity Liabilities, Fair Value Disclosure Fair value of warrants Warrants and Rights Outstanding Warrants outstanding Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Sale of Stock [Axis] Sale of Stock [Domain] This member represents at market offering. At Market Offering [Member] At Market Offering ATM Distribution Agreement Option Indexed to Issuer's Equity, Type [Axis] Option Indexed to Issuer's Equity, Type [Domain] This member stands for Global Share Option Plan 2014 And US Stock Option And Incentive Plan 2014. Global Share Option Plan 2014 And US Stock Option And Incentive Plan 2014 [Member] Global Share Option Plan 2014 And US Stock Option And Incentive Plan 2014 Restricted Stock [Member] Restricted Stock Share-based Compensation Arrangement by Share-based Payment Award [Line Items] STOCK CAPITAL Stock Issued During Period, Value, New Issues Aggregate offering amount Warrants and Rights Outstanding, Term Warrants term Proceeds from Issuance of Common Stock Gross proceeds Class of Warrant or Right, Exercise price Class of warrant exercise price Stock Issued During Period, Shares, Issued for Services Issuance of common stock Common Stock, Capital Shares Reserved for Future Issuance Future issuance of common stock Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Unrecognized compensation cost Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted average period Stock Repurchased During Period, Value Repurchased Common Stock Value Stock Repurchased During Period, Shares Stock Repurchased Share-based Compensation Compensation expense (income) Total stock-based compensation expense Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Represents the information pertaining to securities purchase agreement. Securities Purchase Agreement [Member] Securities purchase agreement Represents the information pertaining to public offering. Public Offering [Member] Public offering Shares Issued, Price Per Share Purchase price per share Proceeds from Issuance or Sale of Equity Gross proceeds Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum Risk-free interest, Minimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum Risk-free interest, Maximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum Expected volatility, Minimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum Expected volatility, Maximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected life of up to (years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price Fair Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Amount of options, Outstanding at end of period Amount of options, Outstanding at beginning of period Options outstanding at end of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Amount of options, Granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Amount of options, Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Amount of options, Vested at end of period Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted average exercise price, Outstanding at end of period (in dollars per share) Weighted average exercise price, Outstanding at beginning of period (in dollars per share) Exercise price (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted average exercise price, Granted (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Weighted average exercise price, Exercised (in dollars per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted Average exercise Price, Forfeited (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Weighted average exercise price, Vested at end of period (in dollars per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Number of Shares of Restricted Stock, Nonvested at end of period Number of Shares of Restricted Stock, Nonvested at beginning of period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Weighted Average Grant Date Fair Value, Nonvested at end of period Weighted Average Grant Date Fair Value, Nonvested at beginning of period Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms Weighted Average Remaining Contractual Term (Years), Nonvested Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table] Exercise Price Range [Axis] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] This member stands for Exercise Price 0.75. Exercise Price 0.75 [Member] Exercise Price 0.75 This member stands for Exercise Price 1.73. Exercise Price 1.73 This member stands for Exercise Price 2.25. Exercise Price 2.25 [Member] Exercise Price 2.25 This member stands for Exercise Price 2.45. Exercise Price 2.45 [Member] Exercise Price 2.45 This member stands for Exercise Price 2.70. Exercise Price 2.70 [Member] Exercise Price 2.70 This member stands for Exercise Price 3.04. Exercise Price 3.04 [Member] Exercise Price 3.04 This member stands for Exercise Price 4.90. Exercise Price 4.09 [Member] Exercise Price 4.09 This member stands for Exercise Price 7.33. Exercise Price 7.33 [member] Exercise Price 7.33 This member stands for Exercise Price 7.67. Exercise Price 7.67 [Member] Exercise Price 7.67 This member stands for Exercise Price 9.51. Exercise Price 9.51 [member] Exercise Price 9.51 This member stands for Exercise Price 14.95. Exercise Price 14.95 [Member] Exercise Price 14.95 Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items] STOCK CAPITAL Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted average remaining contractual Life - Years Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Options exercisable Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table] Income Statement Location [Axis] Income Statement Location [Domain] Research and Development Expense [Member] Research and development General and Administrative Expense [Member] General and administrative Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] STOCK CAPITAL Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 3 [Member] Level 3 Measurement Input Type [Axis] Measurement Input Type [Domain] Measurement Input, Maturity [Member] Time to expiration Measurement Input, Share Price [Member] Common stock price Measurement Input, Risk Free Interest Rate [Member] Risk-free interest rate Measurement Input, Price Volatility [Member] Volatility Fair Value Measurement Inputs and Valuation Techniques [Line Items] Assumptions used to determine fair value of warrants Warrants and Rights Outstanding, Measurement Input Warrants liabilities, inputs Represents information pertaining to entities. Other [Member] Other grants No definition available. Research And Development Arrangement [Line Items] RESEARCH AND DEVELOPMENT, NET Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs Research and development Research and Development Arrangement, Contract to Perform for Others, Compensation Earned Less: Participation by grants Tax Credit Carryforward [Table] Income Tax Authority [Axis] Income Tax Authority [Domain] Foreign Tax Authority [Member] Israel Domestic Tax Authority [Member] U.S. Tax Credit Carryforward [Line Items] TAXES ON INCOME Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Corporate tax rate Tax Credit Carryforward, Amount Operating Loss Carryforwards Operating loss carryforward Deferred Tax Assets, Gross Net deferred tax asset before valuation allowance Deferred Tax Assets, Valuation Allowance Valuation allowance Deferred Tax Assets, Net Net deferred tax asset Income (Loss) from Continuing Operations before Income Taxes, Domestic United States Income (Loss) from Continuing Operations before Income Taxes, Foreign Israel Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Subsequent Event [Table] Subsequent Event